Harada Industry : Summary of Consolidated Financial Results for the Second Quarter

Summary of Consolidated Financial Results

for the Second Quarter of Fiscal Year Ending March 31, 2024

Company Name: HARADA INDUSTRY CO., LTD.

November 10, 2023

Securities Code: 6904

Listing: Tokyo Stock Exchange

URL:https://www.harada.com

Inquiries: Yoichi Kamijo, Executive Officer

Representative: Yasuharu Miyake, President and Representative Director

Telephone Number: [phone]

Filing Date of Quarterly Report (as Planned): November 10, 2023

Dividend Payable Date (as Planned): -

Preparation of Supplement Material of Quarterly Results: Yes

Convening Briefing of Quarterly Results: None

(Figures are rounded down to the nearest million yen.)

1. Consolidated Financial Results for the Second Quarter of Fiscal Year Ending March 31, 2024

(April 1, 2023 to September 30, 2023)

1) Consolidated Operating Results (Cumulative)

(Percentages indicate percent change from the previous year.)

Net Sales

Operating profit

Ordinary profit

Profit attributable to

owners of parent

Millions of Yen

%

Millions of Yen

%

Millions of Yen

%

Millions of Yen

%

2Q Fiscal 2023

22,762

15.9

625

-

320

-

2,555

-

2Q Fiscal 2022

19,636

7.8

(232)

-

(115)

-

(418)

-

(Notes) Comprehensive income:

2Q Fiscal 2023: 3,278 million yen (221.3%)

2Q Fiscal 2022: 1,020 million yen (29.2%)

Basic earnings

Diluted earnings

per share

per share

Yen

Yen

2Q Fiscal 2023

117.51

-

2Q Fiscal 2022

(19.23)

-

2) Consolidated Financial Positions

Total assets

Net assets

Capital adequacy ratio

Net assets per share

Millions of Yen

Millions of Yen

%

Yen

2Q Fiscal 2023

38,507

14,336

37.2

659.13

Fiscal 2022

40,131

11,166

27.8

513.38

(Notes) Owner's

equity:

2Q Fiscal 2023: 14,336 million yen

Fiscal 2022: 11,166 million yen

2. Dividends

Annual dividends

First quarter

Second quarter

Third quarter

Year end

Annual

Yen

Yen

Yen

Yen

Yen

Fiscal 2022

-

0.00

-

5.00

5.00

Fiscal 2023

-

0.00

Fiscal 2023

-

15.00

15.00

(forecasts)

(Notes1)Revisions of dividends forecasts from the most recent announcement: Yes

(Notes2)The detail of year-end dividend of Fiscal 2023 (forecast); ordinary dividend 7.50 yen, extra dividend 7.50 yen.

3. Consolidated Forecasts (April 1, 2023 to March 31, 2024)	(Percentages indicate percent change from the previous year.)
	Net sales		Operating profit		Ordinary profit		Profit attributable to	Basic earnings
				owners of parent		per share
	Millions of yen		%	Millions of yen		%	Millions of yen		%	Millions of yen		%	Yen
Full year	44,000		4.5	650		-	350		-	1,500		-	68.96

(Notes) Revisions of financial forecasts from the most recent announcement: Yes

*Notes

1. Changes in significant subsidiaries during the period (changes in specified subsidiaries involving changes in the scope of consolidation): None
   Number of subsidiaries newly consolidated: - (Name: - )
   Number of subsidiaries excluded from consolidated: - (Name: - )
2. Applying of specific accounting methods in preparation for quarterly consolidated financial statements: None
3. Changes in accounting policies, changes in accounting estimates and restatements
4. 1. Changes in accounting policies associated with the revisions of accounting standards: None
   2. Changes in accounting policies other than above: None
   3. Changes in accounting estimates: None
   4. Restatements: None
5. Numbers of shares issued and outstanding (common stock)

1. Numbers of shares issued and outstanding (including treasury stock):
2. Numbers of treasury stock:
3. Average number of shares outstanding:

2Q Fiscal 2023	21,758,000	Fiscal 2022	21,758,000
2Q Fiscal 2023	7,268	Fiscal 2022	7,218
2Q Fiscal 2023	21,750,752	2Q Fiscal 2022	21,750,782

*This summary of financial results is exempt from quarterly review procedures by certified public accountants or an audit firm.

*Explanation regarding the appropriate use of financial forecasts and other special remarks

The forecast figures are based on information and assumptions associated to variable factors may impact on future results available at the date of disclosure of this document. Actual results may differ materially from various factors.